NEW YORK (GenomeWeb) – Quest Diagnostics reported Thursday that its first quarter revenues grew around 1 percent from the previous year and beat analysts' consensus estimate.

For the three months ended March 31, Quest reported $1.86 billion in revenues compared to $1.84 billion for the first quarter in 2015 and exceeding Wall Street's expectation of $1.82 billion.

On an equivalent basis, excluding Q1 2015 revenues from the firm's clinical trials testing business that is now part of the Q2 Solutions joint venture, revenue growth was nearly 4 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.